In the case of the UPS cargos whose excessive release provokes pathologies, such as IL-1β in diabetes and AD, α-synuclein in PD, and HMGB1 in sepsis, downregulation of their releases would be beneficial for disease control. This evidence concerns the gene IL1B and Parkinson disease.